| Ytd | -28.69% | |
| 1y | -77.27% |
| Open | 2.54 | Prev Close | 2.56 | Low | 2.51 | High | 2.56 | Mkt Cap | 236.78M |
| Vol | 95.46K | Avg Vol | 1.18M | EPS | -0.46 | P/E | -5.55 | Forward P/E | -17.25 |
| Beta | 1.14 | Short Ratio | 10.82 | Inst. Own | 32.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-16 | 50-d Avg | 2.68 | 200-d Avg | 4.33 | 1yr Est | 35.47 |
AVXL News
NEW YORK, May 22, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (N
NEW YORK, May 06, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (N
Findings underpin the scientific rationale for Anavex's targeted autophagy approach with orally admi
NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”)
Dialogue continues with European Medicines Agency (EMA) to advance the development program of oral b
NEW YORK, March 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investor
The Dow Jones index gained over 300 points, with the S&P 500 and NASDAQ also rising. Cintas Corp
US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics sur
This decision follows feedback from the European Medicines Agency's (EMA) Committee for Medicinal Pr
NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”)
New data show brain-volume preservation correlates with patient outcomes Long-term clinical data ind
Findings underpin potential of Anavex' lead candidate blarcamesine through its upstream mechanism of
New data show that blarcamesine completely rescued impaired motor function Biomarker of nerve fiber
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”)
NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (
Anavex Life Sciences (AVXL) might move higher on growing optimism about its earnings prospects, whic
Here is how Anavex Life Sciences (AVXL) and Cabaletta Bio, Inc. (CABA) have performed compared to th
Anavex Life Sciences Corp. (AVXL) Q1 2026 Earnings Call Transcript
Company to host a webcast today at 8:30 am Eastern Time
Webcast and Conference Call To be Held Monday, February 9, 2026, 8:30 am ET Webcast and Conference C
Anavex Life Sciences (NASDAQ: AVXL) outlined its strategy to develop oral, precision-medicine therap
Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quart
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the co
On Tuesday, 647 companies set new 52-week lows.
On Monday, 369 companies set new 52-week lows.
During Thursday's session, 406 companies made new 52-week lows.
On Tuesday, 386 stocks made new 52-week lows.
Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earn
On Friday, 1043 companies hit new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report